secwatch.observer — SEC 8-K summary
======================================

Issuer:     Matinas BioPharma Holdings, Inc. (MTNB)
CIK:        0001582554
Form:       8-K
Filed at:   2026-09-04T21:00:30+00:00
Accession:  0001493152-26-041577
Event type: regulatory
Sentiment:  negative
Materiality: 0.60
Item codes: 3.01, 8.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Matinas BioPharma receives NYSE American non-compliance notice for equity below $2M
--------------------------------------------------------------------------------

- Received notice Aug 31, 2026: stockholders' equity $1.8M as of June 30, 2026, below $2.0M minimum under Section 1003(a)(i).
- Also non-compliant with Sections 1003(a)(ii) and (iii) (equity below $4M and $6M) as previously disclosed.
- Plan accepted by NYSE American; plan period through Oct 2, 2027 to regain compliance; delisting proceedings if not.
- No immediate impact on listing; shares continue trading on NYSE American under MTNB with .BC indicator.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1582554/000149315226041577/0001493152-26-041577-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1582554/000149315226041577/form8-k.htm
  HTML page:      https://secwatch.observer/filing/0001493152-26-041577

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer